Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Irritable Bowel Syndrome, December 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 82 articles:
HTML format


 

Single Articles

  1. XIA Y, Tan W, Yuan F, Lin M, et al
    Luteolin Attenuates Oxidative Stress and Colonic Hypermobility in Water Avoidance Stress Rats by Activating the Nrf2 Signaling Pathway.
    Mol Nutr Food Res. 2023 Nov 30:e2300126. doi: 10.1002/mnfr.202300126.
    PubMed    
    Abstract available

  2. HUNG TH, Wang CY, Lee HF
    Update in diagnosis and management of irritable bowel syndrome.
    Tzu Chi Med J. 2023;35:306-311.
    PubMed    
    Abstract available

  3. ABRAHAM P, Dhoble P, Desai D, Joshi A, et al
    Self-reported food intolerances in an Indian population: Need for individualization rather than a universal low-FODMAP diet.
    JGH Open. 2023;7:772-776.
    PubMed    
    Abstract available

  4. TAHIRI M, Johnsrud C, Steffensen IL
    Evidence and hypotheses on adverse effects of the food additives carrageenan (E 407)/processed Eucheuma seaweed (E 407a) and carboxymethylcellulose (E 466) on the intestines: a scoping review.
    Crit Rev Toxicol. 2023 Nov 30:1-51. doi: 10.1080/10408444.2023.2270574.
    PubMed    
    Abstract available

  5. KILPATRICK LA, Gupta A, Tillisch K, Labus JS, et al
    Neural correlates of perceived and relative resilience in male and female patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2023 Nov 29:e14710. doi: 10.1111/nmo.14710.
    PubMed    
    Abstract available

  6. HAJIZADEH MALEKI B, Tartibian B, Mooren FC, FitzGerald LZ, et al
    Retraction notice to "Low-to-moderate intensity aerobic exercise training modulates irritable bowel syndrome through antioxidative and inflammatory mechanisms in women: Results of a randomized controlled trial" [Cytokine 102 (2018) 18-25].
    Cytokine. 2023 Nov 28:156454. doi: 10.1016/j.cyto.2023.156454.
    PubMed    


  7. CUI L, Hua Y, Zou S, Gu C, et al
    Combination of fenchone and sodium hyaluronate ameliorated constipation-predominant irritable bowel syndrome and underlying mechanisms.
    Chem Biol Drug Des. 2023 Nov 29:e14397. doi: 10.1111/cbdd.14397.
    PubMed    
    Abstract available

  8. MISHRA V, Sharma K, Bose A, Maisonneuve P, et al
    The evolutionary divergence of receptor guanylyl cyclase C has implications for preclinical models for receptor-directed therapeutics.
    J Biol Chem. 2023 Nov 27:105505. doi: 10.1016/j.jbc.2023.105505.
    PubMed    
    Abstract available

  9. BARTON JR, Londregan AK, Alexander TD, Entezari AA, et al
    Enteroendocrine cell regulation of the gut-brain axis.
    Front Neurosci. 2023;17:1272955.
    PubMed    
    Abstract available

  10. THOMPSON W, Swain S, Zhao SS, Kamps A, et al
    Causal association between subtypes of osteoarthritis and common comorbidities: A Mendelian randomisation study.
    Osteoarthr Cartil Open. 2023;5:100414.
    PubMed    
    Abstract available

  11. ARABPOUR E, Alijanzadeh D, Sadeghi A, Khoshdel S, et al
    Gluten restriction in irritable bowel syndrome, yes or no?: a GRADE-assessed systematic review and meta-analysis.
    Front Nutr. 2023;10:1273629.
    PubMed    
    Abstract available

  12. BOWES MR, Speicher MR, Tran LT, Santiago PN, et al
    Osteopathic Manipulative Medicine and Its Role in Psychiatry.
    Cureus. 2023;15:e47045.
    PubMed    
    Abstract available

  13. ALHUSSAINI KI
    Microscopic Colitis: A Review Article.
    Cureus. 2023;15:e47150.
    PubMed    
    Abstract available

  14. MAKKAWY EA, Abdulaal IE, Kalaji FR, Makkawi M, et al
    Prevalence, Risk Factors, and Management of Irritable Bowel Syndrome in Saudi Arabia: A Systematic Review.
    Cureus. 2023;15:e47440.
    PubMed    
    Abstract available

  15. AHLAWAT GM, Singh PK
    Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review.
    Curr Ther Res Clin Exp. 2023;99:100721.
    PubMed    
    Abstract available

  16. YIN J, Chen JD
    Noninvasive electrical neuromodulation for gastrointestinal motility disorders.
    Expert Rev Gastroenterol Hepatol. 2023.
    PubMed    
    Abstract available

  17. BRUSHETT S, Gacesa R, Vich Vila A, Brandao Gois MF, et al
    Gut feelings: the relations between depression, anxiety, psychotropic drugs and the gut microbiome.
    Gut Microbes. 2023;15:2281360.
    PubMed    
    Abstract available

  18. LUO QQ, Cheng L, Wang B, Chen X, et al
    ZBTB20 mediates stress-induced visceral hypersensitivity via activating the NF-kappaB/transient receptor potential channel pathway.
    Neurogastroenterol Motil. 2023 Nov 27:e14718. doi: 10.1111/nmo.14718.
    PubMed    
    Abstract available

  19. KASSEM AM, Almukainzi M, Faris TM, Ibrahim AH, et al
    A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.
    Eur J Pharm Sci. 2023;192:106652.
    PubMed    
    Abstract available

  20. HENGGELER C
    Irritable bowel syndrome and endometriosis: diagnosis, similarities, and nutritional management.
    Br J Nurs. 2023;32:S14-S20.
    PubMed    
    Abstract available

  21. PARIGI TL, Vieujean S, Paridaens K, Dalgaard K, et al
    Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.
    Microorganisms. 2023;11:2806.
    PubMed    
    Abstract available

  22. ZHOU J, Ho V
    Role of Baseline Gut Microbiota on Response to Fiber Intervention in Individuals with Irritable Bowel Syndrome.
    Nutrients. 2023;15:4786.
    PubMed    
    Abstract available

  23. LEE JY, Yau CY, Loh CYL, Lim WS, et al
    Examining the Association between Coffee Intake and the Risk of Developing Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Nutrients. 2023;15:4745.
    PubMed    
    Abstract available

  24. PARAMYTHIOTIS D, Karlafti E, Didagelos M, Fafouti M, et al
    Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review.
    Medicina (Kaunas). 2023;59:1961.
    PubMed    
    Abstract available

  25. VELHO RV, Werner F, Mechsner S
    Endo Belly: What Is It and Why Does It Happen?-A Narrative Review.
    J Clin Med. 2023;12:7176.
    PubMed    
    Abstract available

  26. MOLOTLA-TORRES DE, Guzman-Mejia F, Godinez-Victoria M, Drago-Serrano ME, et al
    Role of Stress on Driving the Intestinal Paracellular Permeability.
    Curr Issues Mol Biol. 2023;45:9284-9305.
    PubMed    
    Abstract available

  27. KUMAVATH R, Pavithran H, Paul S, Anju VT, et al
    Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review).
    Int J Oncol. 2024;64:4.
    PubMed    
    Abstract available

  28. VELEZ LOPEZ A, Waddell A, Antonacci S, Castillo D, et al
    Microbiota-derived butyrate dampens linaclotide stimulation of the guanylate cyclase C pathway in patient-derived colonoids.
    Neurogastroenterol Motil. 2023;35:e14681.
    PubMed    
    Abstract available

  29. BURTON MURRAY H, Ljotsson B, Healy B, Van Oudenhove L, et al
    Brief cognitive-behavioral treatment for avoidant/restrictive food intake disorder in the context of functional dyspepsia: Study protocol for a feasibility randomized controlled trial.
    Contemp Clin Trials. 2023;134:107336.
    PubMed    
    Abstract available

  30. KITAGHENDA FK, Hong J, Shao Y, Yao L, et al
    The Prevalence of Small Intestinal Bacterial Overgrowth After Roux-en-Y Gastric Bypass (RYGB): a Systematic Review and Meta-analysis.
    Obes Surg. 2023 Dec 7. doi: 10.1007/s11695-023-06974.
    PubMed    
    Abstract available

  31. XIA D, Han X, Zeng Y, Wang J, et al
    Disease trajectory of high neuroticism and the relevance to psychiatric disorders: A retro-prospective cohort study.
    Acta Psychiatr Scand. 2023 Dec 6. doi: 10.1111/acps.13645.
    PubMed    
    Abstract available

  32. NA W, Sohn C
    Food contributing to fermentable oligosaccharide, disaccharide, monosaccharide, and polyols intake in Korean adults.
    Nutr Res Pract. 2023;17:1201-1210.
    PubMed    
    Abstract available

  33. WERTHEIM B, Aarts EE, de Roos C, van Rood YR, et al
    The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS).
    Trials. 2023;24:785.
    PubMed    
    Abstract available

  34. RHEW K
    Association Between Migraine and Gastrointestinal Disease in Pediatric Patients: A Propensity Score Weighting Approach.
    Neuropsychiatr Dis Treat. 2023;19:2607-2615.
    PubMed    
    Abstract available

  35. SHEN Z, Qiu B, Chen L, Zhang Y, et al
    Common gastrointestinal diseases and chronic obstructive pulmonary disease risk: a bidirectional Mendelian randomization analysis.
    Front Genet. 2023;14:1256833.
    PubMed    
    Abstract available

  36. LIU W, Choi SJ, George D, Li L, et al
    Untethered shape-changing devices in the gastrointestinal tract.
    Expert Opin Drug Deliv. 2023 Dec 4. doi: 10.1080/17425247.2023.2291450.
    PubMed    
    Abstract available

  37. STAAL J, Driege Y, Van Gaever F, Steels J, et al
    Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family.
    FEBS J. 2023 Dec 14. doi: 10.1111/febs.17035.
    PubMed    
    Abstract available

  38. LAI BY, Hong MY, He YJ, Li X, et al
    Effect of acupuncture and moxibustion on intestinal flora in the rats with diarrhea-predominant irritable bowel syndrome based on 16S rDNA technique.
    Zhongguo Zhen Jiu. 2023;43:1411-1421.
    PubMed    
    Abstract available

  39. ALKALASH SH, Almagadi RA, Alamri SM, Al-Amri LA, et al
    Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults in Al-Qunfudah Governorate, Saudi Arabia.
    Cureus. 2023;15:e48639.
    PubMed    
    Abstract available

  40. LUPIANEZ-MERLY C, Dilmaghani S, Camilleri M
    Recent developments in diagnosing bile acid diarrhea.
    Expert Rev Gastroenterol Hepatol. 2023.
    PubMed    
    Abstract available

  41. TRAVERS P, Lacy BE, Cangemi DJ
    Irritable bowel syndrome - less irritable, or better treatments?
    Curr Opin Gastroenterol. 2024;40:27-33.
    PubMed    
    Abstract available

  42. HIJNE K, Gerritsen L, Pinto AM, da Silva JAP, et al
    A taxonomy of threat and soothing influences in rheumatic and musculoskeletal diseases and central sensitivity syndromes.
    Int J Clin Health Psychol. 2024;24:100420.
    PubMed    
    Abstract available

  43. LV CL, Song GQ, Liu J, Wang W, et al
    Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China.
    World J Gastroenterol. 2023;29:5657-5667.
    PubMed    
    Abstract available

  44. CHADWICK AL, Lisha NE, Lubensky ME, Dastur Z, et al
    Localized and Widespread Chronic Pain in Sexual and Gender Minority People - An Analysis of The PRIDE Study.
    medRxiv. 2023 Nov 28:2023.11.27.23299101. doi: 10.1101/2023.11.27.23299101.
    PubMed    
    Abstract available

  45. OROCK A, Johnson AC, Mohammadi E, Greenwood-Van Meerveld B, et al
    Environmental enrichment reverses stress-induced changes in the brain-gut axis to ameliorate chronic visceral and somatic hypersensitivity.
    Neurobiol Stress. 2023;28:100590.
    PubMed    
    Abstract available

  46. CUI L, Zhang B, Zou S, Liu J, et al
    Fenchone Ameliorates ConstipationPredominant Irritable Bowel Syndrome via Modulation of SCF/c-Kit Pathway and Gut Microbiota.
    J Microbiol Biotechnol. 2023;34:1-12.
    PubMed    
    Abstract available

  47. VARMA R, Staab JP, Matey ET, Wright JA, et al
    Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions.
    Neurogastroenterol Motil. 2023 Dec 10:e14722. doi: 10.1111/nmo.14722.
    PubMed    
    Abstract available

  48. SWIFT B, Taneri B, Becker CM, Basarir H, et al
    Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: results from an Eastern Mediterranean population.
    Eur J Public Health. 2023 Dec 9:ckad216. doi: 10.1093.
    PubMed    
    Abstract available

  49. WEI Z, Yang Y, Du T, Hao Y, et al
    Exercise is inversely associated with functional dyspepsia among a sample of Chinese male armed police recruits.
    BMC Gastroenterol. 2023;23:430.
    PubMed    
    Abstract available

  50. BENFANTE A, Cisaro F, Ribaldone DG, Castelli L, et al
    Inflammatory Bowel Disease and Irritable Bowel Syndrome: What Differences in Mentalization Abilities? A Scoping Review.
    Int J Environ Res Public Health. 2023;20:7125.
    PubMed    
    Abstract available

  51. PENA-GALO EM, Wurzelmann D, Alcedo J, Pena R, et al
    Enduring association between irritable bowel syndrome and war trauma during the Nicaragua civil war period: A population-based study.
    World J Gastroenterol. 2023;29:5953-5961.
    PubMed    
    Abstract available

  52. ALYASI AS, Altawili MA, Alabbadi AF, Hamdi AHA, et al
    Pharmacological Management for Pediatric Irritable Bowel Syndrome: A Review.
    Cureus. 2023;15:e49197.
    PubMed    
    Abstract available

  53. GORDON M, Benninga MA, Borlack R, Borrelli O, et al
    ESPGHAN and NASPGHAN 2023 protocol for paediatric FAPD treatment guidelines (standard operating procedure).
    BMJ Paediatr Open. 2023;7:e002166.
    PubMed    
    Abstract available

  54. GONG L, Liu F, Liu J, Wang J, et al
    Dietary fiber (oligosaccharide and non-starch polysaccharide) in preventing and treating functional gastrointestinal disorders - Challenges and controversies: A review.
    Int J Biol Macromol. 2023 Dec 19:128835. doi: 10.1016/j.ijbiomac.2023.128835.
    PubMed    
    Abstract available

  55. CUI L, Zou S, Liu J, Lv H, et al
    Potential effects of sodium hyaluronate on constipation-predominant irritable bowel syndrome.
    Int Immunopharmacol. 2023;127:111404.
    PubMed    
    Abstract available

  56. MASOOD R, LeRoy TE, Moverman MA, Feldman MW, et al
    Functional Somatic Syndromes Are Associated With Varied Postoperative Outcomes and Increased Opioid Use After Spine Surgery: A Systematic Review.
    Global Spine J. 2023 Nov 21:21925682231217706. doi: 10.1177/21925682231217706.
    PubMed    
    Abstract available

  57. TORNIC J, Engeler D
    Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis.
    Curr Opin Urol. 2023 Dec 21. doi: 10.1097/MOU.0000000000001158.
    PubMed    
    Abstract available

  58. YANG P, Wang T, He YJ, Su SY, et al
    Research Trends of Acupuncture Therapy for Chronic Pain-Related Depression or Anxiety from 2003 to 2023: A Bibliometric Analysis.
    J Pain Res. 2023;16:4301-4315.
    PubMed    
    Abstract available

  59. LIU T, Wu ML, Deng GY, He Y, et al
    [Linderae Radix water extract treats diarrhea-predominant irritable bowel syndrome in rats: a serum metabolomics study].
    Zhongguo Zhong Yao Za Zhi. 2023;48:5356-5364.
    PubMed    
    Abstract available

  60. ACCIARINO A, Diwakarla S, Handreck J, Bergola C, et al
    The role of the gastrointestinal barrier in obesity-associated systemic inflammation.
    Obes Rev. 2023 Dec 18:e13673. doi: 10.1111/obr.13673.
    PubMed    
    Abstract available

  61. WANG H, Chen X, Wang S, Zhang H, et al
    Exploration of the causal effects of leukocyte telomere length and four gastrointestinal diseases: a two-sample bidirectional Mendelian randomization study.
    BMC Gastroenterol. 2023;23:446.
    PubMed    
    Abstract available

  62. ZHAO J, Li X, Yang J, Hao X, et al
    Prevalence of and factors associated with symptoms consistent with a diagnosis of irritable bowel syndrome among resident physicians in standardised training in China: a cross-sectional study.
    BMJ Open. 2023;13:e079874.
    PubMed    
    Abstract available

  63. SONG K, Fan Z, Chen Y, Fei G, et al
    Shared decision-making improving efficacy in diarrhoea-dominant irritable bowel syndrome in Chinese outpatient setting: protocol of a prospective, randomised controlled trial.
    BMJ Open. 2023;13:e077605.
    PubMed    
    Abstract available

  64. BONAKDAR RA, Sweeney MM, Garvey C, White AA, et al
    Case Report: Initial Successful Treatment of Migraine and Irritable Bowel Syndrome With a Low-FODMAP Diet.
    J Am Nutr Assoc. 2023 Dec 18:1-6. doi: 10.1080/27697061.2023.2288081.
    PubMed    
    Abstract available

  65. SHE MP, Hsieh YT, Lin LY, Tu CH, et al
    Differential roles of serotonin receptor subtypes in regulation of neurotrophin receptor expression and intestinal hypernociception.
    Histol Histopathol. 2023 Dec 11:18687. doi: 10.14670.
    PubMed    
    Abstract available

  66. LEITE G, de Freitas Germano J, Morales W, Weitsman S, et al
    Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model.
    Gut Microbes. 2024;16:2293170.
    PubMed    
    Abstract available

  67. CURRO D, Ianiro G, Gasbarrini A
    A pharmacokinetic evaluation of tenapanor for the treatment of irritable bowel syndrome with constipation: an update of the literature.
    Expert Opin Drug Metab Toxicol. 2023 Dec 18. doi: 10.1080/17425255.2023.2294937.
    PubMed    
    Abstract available

  68. BLIZARD DA, Adams N, Boomsma DI
    The genetics of neuroticism: Insights from the Maudsley rat model and human studies.
    Personal Neurosci. 2023;6:e6.
    PubMed    
    Abstract available

  69. BHINDER G, Meza-Cardona JM, Low A, Aumais G, et al
    Irritable Bowel Syndrome Patient Experience: A Survey of Patient-Reported Symptoms by Irritable Bowel Syndrome Subtype and Impact on Quality of Life.
    J Can Assoc Gastroenterol. 2023;6:219-228.
    PubMed    
    Abstract available

  70. ZAREI D, Saghazadeh A, Rezaei N
    Subtyping irritable bowel syndrome using cluster analysis: a systematic review.
    BMC Bioinformatics. 2023;24:478.
    PubMed    
    Abstract available

  71. SHIN A
    Editorial: Antibiotics as a risk factor for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2024;59:130-131.
    PubMed    


  72. STALLER K, Ludvigsson JF
    Letter: Antibiotics prescription and new-onset irritable bowel syndrome-Authors' reply.
    Aliment Pharmacol Ther. 2023 Dec 8. doi: 10.1111/apt.17827.
    PubMed    


  73. VILLANUEVA-MILLAN MJ, Leite G, Morales W, Sanchez M, et al
    Hydrogen Sulfide Producers Drive a Diarrhea-Like Phenotype and a Methane Producer Drives a Constipation-Like Phenotype in Animal Models.
    Dig Dis Sci. 2023 Dec 7. doi: 10.1007/s10620-023-08197.
    PubMed    
    Abstract available

  74. SILVERNALE C, Garcia-Fischer I, Staller K
    Relationship Between Psychological Trauma and Irritable Bowel Syndrome and Functional Dyspepsia in a Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome Patient Population.
    Dig Dis Sci. 2023 Dec 19. doi: 10.1007/s10620-023-08201.
    PubMed    
    Abstract available

  75. WANG YN, Zhou LY, Huang YH, Jiang M, et al
    The incidence and predisposing factors for irritable bowel syndrome following COVID-19: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1097/MEG.0000000000002688.
    PubMed    
    Abstract available

  76. SEHGAL K, Yadav D, Saha S, Mara K, et al
    Sex-Discordant Fecal Microbiota Transplantation for C. difficile may increase risk of post-infection irritable bowel syndrome.
    Gastroenterology. 2023 Dec 4:S0016-5085(23)05570.
    PubMed    


  77. SO SY, Badu S, Wu Q, Yalcinkaya N, et al
    Sex-dependent efficacy of dietary fiber in pediatric functional abdominal pain.
    Gastroenterology. 2023 Dec 18:S0016-5085(23)05607.
    PubMed    
    Abstract available

  78. GHOSHAL UC, Mustafa U, Mukhopadhyay SK
    FODMAP meal challenge test: a novel investigation to predict response to low-FODMAP diet in non-constipating irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Nov 28. doi: 10.1111/jgh.16424.
    PubMed    
    Abstract available

  79. HARRIS E
    Trial Confirms Antidepressant Improves IBS in Primary Care.
    JAMA. 2023;330:1827-1828.
    PubMed    


  80. CHOU MC, Jou IM, Chen HT, Chang R, et al
    Correspondence on "Patients with ankylosing spondylitis have high risk of irritable bowel syndrome.".
    Postgrad Med. 2023 Dec 13:1. doi: 10.1080/00325481.2023.2277148.
    PubMed    


  81. ALIHOSSEINI S, Khodaei F, Jaberinezhad M, Azari M, et al
    Evaluation of gallbladder contractility and Doppler findings in patients with irritable bowel syndrome; a case-control study.
    Scand J Gastroenterol. 2023 Nov 30:1-8. doi: 10.1080/00365521.2023.2287989.
    PubMed    
    Abstract available

  82. TIAN J, Li T, Zhao J, Li D, et al
    Efficacy of different courses of acupuncture for diarrhea irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    PLoS One. 2023;18:e0295077.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;